BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 36533966)

  • 1. Improved hemophagocytic lymphohistiocytosis index predicts prognosis of adult Epstein-Barr virus-associated HLH patients.
    Yao S; He L; Zhang R; Liu M; Hua Z; Zou H; Wang Z; Wang Y
    Ann Med; 2023 Dec; 55(1):89-100. PubMed ID: 36533966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sintilimab treatment for chronic active Epstein-Barr virus infection and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children.
    Chen R; Lin Q; Zhu Y; Shen Y; Xu Q; Tang H; Cui N; Jiang L; Dai X; Chen W; Li X
    Orphanet J Rare Dis; 2023 Sep; 18(1):297. PubMed ID: 37736751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An analysis of sintilimab combined with ruxolitinib as compassionate therapy for 12 adults with EBV-associated hemophagocytic lymphohistiocytosis.
    Xu Y; Li W; Gan J; He X; Huang X
    Ann Hematol; 2023 Dec; 102(12):3325-3333. PubMed ID: 37787838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary hemophagocytic lymphohistiocytosis in pediatric patients with visceral leishmaniasis and Epstein-Barr virus infection.
    Li Y; Li S; Lu N; Wang W; Wang D
    Ann Hematol; 2024 May; 103(5):1541-1547. PubMed ID: 38467825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical laboratory Analysis of EB Virus Associated Hemophagocytic Lymphohistiocytosis in Children.
    Hao G; Jiang L; Wen L; Guo W; Geng W; Li Q
    Altern Ther Health Med; 2024 Apr; ():. PubMed ID: 38639627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment outcomes and prognostic analysis of 61 Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis].
    Zeng X; Wei N; Wang Y; Wang J; Zhang J; Wu L; Huang W; Gao Z; Pei R; Chen J; Jin Z; Wang Z
    Zhonghua Xue Ye Xue Za Zhi; 2015 Jun; 36(6):507-10. PubMed ID: 26134018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rescue of HLH with T and B Lymphocyte Involvement Due to Epstein-Barr Virus by PD-1 Inhibitor/Ruxolitinib and Rituximab Combination Regimens: A Case Report.
    Zhu M; Zhang J; Shi Q; Sun X; Wang H; Sun M; Liu Y
    Iran J Immunol; 2023 Dec; 20(4):466-472. PubMed ID: 37873944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of biomarkers for the early identification of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in infectious mononucleosis.
    Cai L; Xing Y; Xia Y; Zhang Z; Luo Z; Tang Y; Chen Y; Xu X
    BMC Infect Dis; 2023 Oct; 23(1):728. PubMed ID: 37880605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrum of neuroradiological manifestations in primary hemophagocytic lymphohistiocytosis: a comparative study of EBV-induced versus non-EBV-induced forms in 75 genetically confirmed pediatric cases.
    Charpentier H; Roux CJ; Leroux P; Briand C; Levy R; Dangouloff-Ros V; Desguerre I; Neven B; Moshous D; Boddaert N
    Eur Radiol; 2023 Oct; 33(10):7149-7159. PubMed ID: 37171488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of plasma proteomic profiles of patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis and infectious mononucleosis.
    Haruta K; Suzuki T; Yamaguchi M; Fukuda Y; Torii Y; Takahashi Y; Ito Y; Kawada JI
    J Med Virol; 2024 Feb; 96(2):e29450. PubMed ID: 38304956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-Cell Transcriptomic Analysis of Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis.
    Suzuki T; Sato Y; Okuno Y; Torii Y; Fukuda Y; Haruta K; Yamaguchi M; Kawamura Y; Hama A; Narita A; Muramatsu H; Yoshikawa T; Takahashi Y; Kimura H; Ito Y; Kawada JI
    J Clin Immunol; 2024 Apr; 44(4):103. PubMed ID: 38642164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic scoring system for pediatric Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis based on baseline characteristics: A multicenter retrospective study.
    Kong Q; Li M; Wang J; Wu L; Zhou D; Yang M; Xu X; Tan Z; Wu X; Wang Z
    Pediatr Blood Cancer; 2024 Feb; 71(2):e30772. PubMed ID: 37974392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in patients with secondary hemophagocytic lymphohistioc ytosis in a Chinese cohort.
    Pei Y; Zhu J; Yao R; Cao L; Wang Z; Liang R; Jia Y; Su Y
    Ann Hematol; 2024 Mar; 103(3):695-703. PubMed ID: 38265737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Nationwide Retrospective Analysis of Allogeneic Hematopoietic Stem Cell Transplantation for Adult Hemophagocytic Lymphohistiocytosis.
    Kim H; Mizuno K; Masuda K; Sakurai M; Ara T; Naito K; Uehara Y; Yamamoto G; Osada M; Machida S; Horio T; Fukushima K; Mori Y; Ichinohe T; Fukuda T; Atsuta Y; Kataoka K
    Transplant Cell Ther; 2024 Apr; 30(4):419.e1-419.e12. PubMed ID: 38266963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Easily Overlooked Disease: Hemophagocytic Syndrome.
    Chen Y; Zhu YM; Gan YL; Jiang J; Jiang T
    Clin Lab; 2023 Nov; 69(11):. PubMed ID: 37948476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Report of Two Contrasting Cases of Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis: Comparison to Infectious Mononucleosis and Flow Cytometric Analysis of Bone Marrow.
    Ono S; Yoshimoto K; Matsubara M; Nishimura N; Kawashima H; Yoneima R; Yada N; Nishio K
    Int Med Case Rep J; 2024; 17():43-49. PubMed ID: 38269069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric hemophagocytic lymphohistiocytosis: A rarely diagnosed entity in a developing country.
    Cleves D; Lotero V; Medina D; Perez PM; Patiño JA; Torres-Canchala L; Olaya M
    BMC Pediatr; 2021 Sep; 21(1):411. PubMed ID: 34537050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical characteristics of primary hemophagocytic lymphohistiocytosis associated with perforin gene deficiency: a single-center retrospective study].
    Yu MZ; Wu L; Zhang J; Wang JS; Wang YN; Wang Z
    Zhonghua Xue Ye Xue Za Zhi; 2023 Jul; 44(7):572-577. PubMed ID: 37749038
    [No Abstract]   [Full Text] [Related]  

  • 19. Haemophagocytic lymphohistiocytosis secondary to Epstein-Barr and cytomegalovirus coinfection.
    Nasir AZ; Khan N
    BMJ Case Rep; 2024 May; 17(5):. PubMed ID: 38806401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [L-DEP regimen salvage therapy for refractory primary hemophagocytic lymphohistiocytosis triggered by Epstein-Barr virus infection in 4 children].
    Zhao YZ; Ma HH; Lian HY; Wang D; Wang TY; Zhang R
    Zhonghua Er Ke Za Zhi; 2024 May; 62(5):467-472. PubMed ID: 38623016
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.